Healthcare -
Biotechnology - NYSE - CH
$ 1.83
4.57 %
$ 177 M
Market Cap
-0.77
P/E
ADCT - STOCK-BASED COMPENSATION
Stock-based Compensation ADCT - ADC Therapeutics SA
13.5 M
LAST VALUE
-52.76%
2 YEAR CAGR
95.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR